MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Revenues Recognized under Agreement

Revenues recognized under the agreement were as follows (in thousands):

	Year Ended December 31,
	2025		2024
Revenue related to Genentech agreement:
Recognition of license revenue	$	—	$	48,679
Research services	—		1,321
Total	$	—	$	50,000